Simon Khagi, MD, has been appointed medical director of Dartmouth Cancer Center in Manchester, Nashua and Concord. He is also the associate Oncology Service Line director for Southern New Hampshire and assistant professor of Medicine, Geisel School of Medicine at Dartmouth.
Khagi provides leadership for hematology and medical oncology care at the Dartmouth Cancer Center in Manchester, Nashua and future sites in New Hampshire, as well as patient care and direct oversight of clinical personnel. He works with clinic administration to ensure that timely care of the highest quality is provided to our patients.
Khagi comes to Dartmouth Health after serving as the assistant professor for the Department of Medicine and Department of Neurosurgery at the University of North Carolina (UNC) School of Medicine, where he was the director of the UNC Neuro-Oncology Program. We are looking forward to Khagi’s contributions to our continued growth toward leading the nation in translating cancer discoveries, seeking the most impactful innovations in cancer prevention, diagnosis and treatment.
He earned a medical degree from the University of Missouri-Kansas City School of Medicine and completed a residency in Internal Medicine at Dartmouth-Hitchcock Medical Center, Geisel School of Medicine. He trained through a fellowship in Hematology/Oncology at Tufts Medical Center, Tufts University School of Medicine, and a fellowship in Neurological Oncology at Duke University School of Medicine.
In addition to his appointments at the Department of Medicine and Department of Neurosurgery at UNC, Khagi’s clinical, academic and administrative experience includes board certification in internal medicine, medical oncology and certification by the United Council for Neurologic Subspecialties in Neuro-Oncology.
Khagi’s scholarly and research interests have centered on improving treatments for patients with aggressive brain tumors such as glioblastoma as well as metastatic disease to the brain from breast and lung cancer. Other areas of specialty:
- Electromagnetic tumor-treating fields.
- Novel cell-based therapies.
- Engineered viral neuro-immunotherapeutics.
- Enhanced imaging techniques for brain tumors.